Pharmnxt Biotech LLP
About Pharmnxt Biotech LLP
Data last updated:
Pharmnxt Biotech LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 05 July 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAJ-9018. Its GSTIN is 27AAUFP4658H1ZJ (Maharashtra). The LLP holds 3 GST registrations, all of them active.
The LLP has a total obligation of contribution of ₹60,000. It is led by designated partners including Nandkumar Vasant Thakare and Sachin Satish Joshi.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹31.89 Cr. For the same year it recorded a net profit of ₹3.31 Cr (net margin 10.4%) and EBITDA of ₹6.42 Cr (EBITDA margin 20.1%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 115% over five years.
The LLP has about 27 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: PharmXnext. As per MCA filings, the LLP has open charges of ₹9.27 Cr and satisfied charges of ₹4.61 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No.705 7th Floor, Lodha Supremus Business District 2 Kolshet Road, Thane, Maharashtra, India – 400607
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Pharmnxt Biotech LLP FY 2025 filings available
Pharmnxt Biotech LLP reported revenue of ₹31.89 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pharmnxt Biotech LLP
Revenue has grown at a compounded annual rate (CAGR) of 115% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharmnxt Biotech LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹31.89 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹3.31 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharmnxt Biotech LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 10.4% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Pharmnxt Biotech are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pharmnxt Biotech LLP
Pharmnxt Biotech LLP is compared with the companies closest to it by revenue in the Healthcare industry (Medical Consumables). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmnxt Biotech LLP this company | ₹31.89 Cr (FY 2024) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Apothecaries Sundries Mfg. Private Limited | ₹28.5 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Gurugram, Haryana, India |
| Bipson Surgical Private Limited | ₹28.31 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Gandhinagar, Gujarat, India |
| Assure Surgilab Private Limited | ₹28.12 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Vijapur, Gujarat, India |
| Surgeine Healthcare (India) Private Limited | ₹27.95 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Gurgaon, Haryana, India |
| P.S.K Pharma Private Limited | ₹27.86 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Harihar, Karnataka, India |
| Amazing Rubber Products Private Limited | ₹27.62 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Kochi, Kerala, India |
| Safeshield India Rubber Products Private Limited | ₹27.5 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Ernakulam, Kerala, India |
| Udaipur Health Care Private Limited | ₹27.15 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Rajasthan, India |
| Kothari Industrial Corporation Limited Listed | ₹27.14 Cr (FY 2024) | •••• | •••• | 163.0% | •••• | Chennai, Tamil Nadu, India |
| Ramson Health Care Private Limited | ₹27.13 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Pharmnxt Biotech by revenue in the Healthcare industry (Medical Consumables), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Designated Partners of Pharmnxt Biotech LLP
Pharmnxt Biotech has 3 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandkumar Vasant Thakare Also directs: Pharmnxt Ekuse Private Limited, Novelgy Ipsolutions LLP | Designated Partner | 01 Apr 2021 | 5 Years 6 Months | Current |
| Sachin Satish Joshi Also directs: Pharmnxt Ekuse Private Limited | Designated Partner | 01 Apr 2021 | 5 Years 6 Months | Current |
| Ankush Kapoor Also directs: Pharmnxt Ekuse Private Limited | Designated Partner | 05 Jul 2017 | 9 Years 3 Months | Current |
Ownership and Shareholding of Pharmnxt Biotech LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmnxt Biotech LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2025 | Hdfc Bank Limited | ₹17.5 Lakh | Open |
| 28 May 2025 | Hdfc Bank Limited | ₹20.99 Lakh | Open |
| 28 Dec 2024 | Yes Bank Limited | ₹8.4 Cr | Open |
| 31 Mar 2022 | Hdfc Bank Limited | ₹48.59 Lakh | Open |
| 28 Apr 2021 | Indusind Bank Ltd. | ₹4.61 Cr | Satisfied |
Total charge records: 5 View all charges
Associated Brands with Pharmnxt Biotech LLP
Pharmnxt Biotech operates one associated brand: PharmXnext. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures single-use storage, mixing, and chromatography solutions for biologics production. | pharmnxtbiotech.com |
Employees and EPFO Compliance at Pharmnxt Biotech LLP
Pharmnxt Biotech LLP has a workforce of 27 employees as of Oct 20, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmnxt Biotech LLP
Pharmnxt Biotech LLP has 6 designated partner changes on record since 2017: 3 appointments and 3 cessations. The latest: Amod Dinkar Pandit ceased to be Designated Partner on 14 May 2021.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pharmnxt Biotech LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmnxt Biotech LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmnxt Biotech LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmnxt Biotech LLP
Pharmnxt Biotech has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUFP4658H1ZJ | Maharashtra | Active | 06 Sep 2017 |
| 36AAUFP4658H1ZK | Telangana | Active | 05 Nov 2021 |
| 27AAUFP4658H2ZI | Maharashtra | Active | 21 Mar 2025 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmnxt Biotech LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmnxt Biotech LLP
Pharmnxt Biotech is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 05 July 2017 (9+ years old) and is registered under LLPIN AAJ-9018.
Pharmnxt Biotech reported revenue of ₹31.89 Cr for FY 2024.
Pharmnxt Biotech has 3 current designated partners:
- Nandkumar Vasant Thakare - Designated Partner
- Sachin Satish Joshi - Designated Partner
- Ankush Kapoor - Designated Partner
Pharmnxt Biotech reported a net profit of ₹3.31 Cr (net margin 10.4%) and EBITDA of ₹6.42 Cr (EBITDA margin 20.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharmnxt Biotech is 30% over three years and 115% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharmnxt Biotech is 27AAUFP4658H1ZJ, registered in Maharashtra. The LLP has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AAUFP4658H1ZK (Telangana), 27AAUFP4658H2ZI (Maharashtra).
The LLPIN (Limited Liability Partnership Identification Number) of Pharmnxt Biotech is AAJ-9018. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Pharmnxt Biotech was incorporated on 05 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pharmnxt Biotech by revenue are Apothecaries Sundries Mfg. Private Limited, Bipson Surgical Private Limited, Assure Surgilab Private Limited, Surgeine Healthcare (India) Private Limited, P.S.K Pharma Private Limited and 5 more, all in the Healthcare industry (Medical Consumables).
Amod Dinkar Pandit ceased to be Designated Partner on 14 May 2021. Nandkumar Vasant Thakare was appointed as Designated Partner on 01 Apr 2021. Sachin Satish Joshi was appointed as Designated Partner on 01 Apr 2021. Pharmnxt Biotech has 6 designated partner changes on record in total.
The registered office of Pharmnxt Biotech is at Office No.705 7th Floor, Lodha Supremus Business District 2 Kolshet Road, Thane, Maharashtra, India – 400607.